LifeMD, a direct-to-patient telehealth company, announced that its wholly-owned allergy telehealth subsidiary, Cleared, has entered into a strategic partnership with Allergenis, a predictive data analytics company specializing in the detection and management of life-threatening food allergies.
The partnership leverages Cleared’s direct-to-patient allergy telehealth infrastructure and marketing expertise and Allergenis’ peanut allergy diagnostic blood test. The partnership also establishes Cleared as the exclusive telehealth provider for the commercial launch of Allergenis’ peanut allergy diagnostic in the direct-to-consumer channel. Read more.
